Develops therapeutics for the treatment of cancer and infectious diseases
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
570
Frequently Asked Questions
What is Market Cap of SciClone Pharmaceuticals, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. SciClone Pharmaceuticals, Inc. market cap is $581.94M.
What is the 52-week high for SciClone Pharmaceuticals, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. SciClone Pharmaceuticals, Inc. 52 week high is $11.43 as of September 13, 2025.
What is the 52-week low for SciClone Pharmaceuticals, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. SciClone Pharmaceuticals, Inc. 52 week low is $8.55 as of September 13, 2025.
What is SciClone Pharmaceuticals, Inc. stock price today?
SciClone Pharmaceuticals, Inc. stock price today is $11.15.
What was SciClone Pharmaceuticals, Inc. stock price yesterday?
SciClone Pharmaceuticals, Inc. stock price yesterday was $11.15.
What is the PE ratio of SciClone Pharmaceuticals, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. SciClone Pharmaceuticals, Inc.’s P/E ratio is 13.60.
What is the Price-to-Book ratio of SciClone Pharmaceuticals, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. SciClone Pharmaceuticals, Inc. P/B ratio is 2.3290.
What is SciClone Pharmaceuticals, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. SciClone Pharmaceuticals, Inc.'s EBITDA is N/A.
What is the 50-day moving average of SciClone Pharmaceuticals, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. SciClone Pharmaceuticals, Inc. 50-day moving average is $11.09.
How many employess does SciClone Pharmaceuticals, Inc. has?
